Delivery Order SPE2DR25D2005-SPE2DR26FE7X8
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,128.12 delivery order on December 3, 2025, for 60 tablets of Corlanor 7.5 mg, a pharmaceutical product used in cardiac care. This is a firm fixed-price, non-set-aside contract with a completion date of December 4, 2025, and performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $4,615.05 to AmerisourceBergen Drug Corp for Corlanor 7.5 mg tablets (60-count units) on August 5, 2025, with completion expected by August 6, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,265.42 to AmerisourceBergen Drug Corp for the supply of Corlanor 5 mg tablets (60-count) on September 11, 2025, with an ultimate completion date of September 12, 2025. This firm fixed price delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,457.28 for Corlanor 5 mg tablets (60-count) on September 2, 2025, with an ultimate completion date of September 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical supply under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,555.55 on September 24, 2025, for the supply of Corlanor 5 mg tablets (60-count units). This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by September 25, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Corlanor 5 mg tablets (60-count) with a ceiling value of $4,484.78. This firm fixed-price delivery order is scheduled for completion by September 19, 2025, and represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Corlanor 5 mg tablets (60-count units) with a ceiling value of $7,155.48 under a firm fixed-price contract. This delivery order represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The award involved...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,110.41 to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Corlanor 5 mg tablets (60-unit packages). This is a firm fixed-price delivery order with an ultimate completion date of December 9, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $1,162.17 delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Corlanor 5 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with a completion date of October 16, 2025, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a $7,495 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, a cardiac medication used to treat heart failure. This competitively awarded, firm fixed-price contract was issued on June 17, 2025, with an ultimate completion date of June 18, 2025, and represents a non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE7X8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,589.66 to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg on December 2, 2025, with completion expected by December 3, 2025. This competitively awarded, firm fixed-price delivery order represents a routine pharmaceutical procurement under a child contract arrangement. The award was placed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle designated SPE2DX and active through December 2026. The IDC serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceuticals, generic medications, brand-name drugs, vaccines, and medical supplies to support military healthcare programs and other federal agencies including the Defense Health Agency and U.S. Coast Guard. The current award for Corlanor, a cardiac medication, exemplifies the company's role as a critical vendor within the federal medical supply chain, fulfilling specialized pharmaceutical requirements through competitively awarded delivery orders on an as-needed basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 12/1/25 |